Total Funding
9
50
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1619698
This company is a private Australian company to develop new medicines by exploiting the immuno-modulatory properties.
Dr Jenny Harry: CEO
About the Company
The company is developing an oral therapeutic candidate, ImmBALANCE®, derived from H. pylori, to treat paediatric allergy – which frequently manifests initially as atopic dermatitis (also known as eczema) and may progress to include food allergies, allergic asthma, allergic rhinitis and other allergic conditions.
